Categories AlphaGraphs, Earnings, Health Care

Mylan (MYL) swings to a profit in Q1, reaffirms FY20 outlook

Mylan N.V. (NASDAQ: MYL) reported its financial results for the quarter ended March 31, 2020, on Monday before the market opens. The company reaffirmed its financial guidance for the full-year 2020.

Mylan (MYL) Q1 2020 earnings review

Mylan swung to a profit in the first quarter of 2020 from a loss last year, helped by higher revenue. The top-line rose by 5% driven by a 4% growth in North America and a 14% jump in Europe segment. The results were driven by overall volume growth, which was favorably impacted by increased customer buying patterns and patient prescription trends resulting from the COVID-19 pandemic, primarily in its Europe segment.

Looking ahead, Mylan remains on track to close the pending combination with Pfizer’s Upjohn Business in the second half of the year. The company reaffirmed its 2020 revenue outlook in the range of $11.5-12.5 billion, absorbing about $200 million of foreign exchange headwinds versus its previous expectations, and adjusted EBITDA of $3.2-3.9 billion, absorbing about $50 million of foreign exchange headwinds.

The company anticipates full-year adjusted free cash flow generation to be consistent with 2019 levels despite the COVID-19 pandemic. Mylan continues to target about $1 billion of debt repayment during 2020 and remains fully committed to its investment-grade credit rating.

Take a look at our Healthcare articles here

Most Popular

V Earnings: Key quarterly highlights from Visa’s Q1 2023 financial results

Visa Inc. (NYSE: V) reported first quarter 2023 earnings results today. Net revenues grew 12% year-over-year to $7.9 billion. GAAP net income rose 6% to $4.2 billion while EPS grew

Earnings: Highlights of Intel’s (INTC) Q4 2022 financial results

Intel Corporation (NASDAQ: INTC) Thursday reported a decline in adjusted earnings and revenues for the fourth quarter. The semiconductor giant also provided guidance for the first quarter of 2023. Fourth-quarter

McCormick (MKC) expects to drive sales growth in 2023 through pricing actions and cost savings

Shares of McCormick & Company Inc. (NYSE: MKC) were down over 5% on Thursday after the company missed expectations on its fourth quarter 2022 results and provided a lower-than-expected earnings

Add Comment
Viewing Highlight